DalsnaFinance

Autism Diagnostics Lab Announces the U.S. Launch of the First Commercial Urine-Based Microbial-Derived Metabolite (MDM™) Gut & Brain Health Test for Autism Screening

Markets PR Newswire By PR Newswire 17 Jun 2026 12:00 1 min read
Autism Diagnostics Lab Announces the U.S. Launch of the First Commercial Urine-Based Microbial-Derived Metabolite (MDM™) Gut & Brain Health Test for Autism Screening

Newly available test measures microbially derived metabolites associated with a distinct autism phenotype Non-invasive screening tool designed to help identify children at risk for autism earlier and support clinical decision-making Test is supported by peer-reviewed research published in...

Newly available test measures microbially derived metabolites associated with a distinct autism phenotype Non-invasive screening tool designed to help identify children at risk for autism earlier and support clinical decision-making Test is supported by peer-reviewed research published in...

Read the full story on PR Newswire → Opens the original article on www.prnewswire.com

Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.